Cite
MLA Citation
C. Resteghini et al.. “Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients.” Best practice & research, vol. 31, no. 3, 2017, pp. 349–361. http://access.bl.uk/ark:/81055/vdc_100053766620.0x000011